Is PKC activation required for leukemia cell differentiation?

Leukemia Research

Volumn 21, Issue 5, 1997, Pages 411-414

  Woloschak, G E ^a  

^a ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; ISOENZYME; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA1;

CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; LEUKEMIA CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030788090     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00121-X     Document Type: Note

References (42)

1. L. Manzel D.E. Macfarlane Protein kinase C is not necessary for transforming growth factor beta induced growth-arrest in leukemia cell lines Leukemia Research 21 1997 403
2. Y. Hong J.F. Martin W. Vainchenker J.D. Erusalimsky Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells Blood 87 1996 123
3. O. Trubiani R.A. Rana L. Stuppia R. Di-Primio Nuclear translocation of beta II PKC isoenzyme in phorbol ester-stimulated KM-3 pre-B human leukemic cells Experimental Cell Research 221 1995 172
4. W.P. Schiemann N.M. Nathanson Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways Journal of Biological Chemistry 269 1994 6376
5. C.N. Lok K.F. Chan T.T. Loh Effects of protein kinase modulators on transferrin receptor expression in human leukaemic HL-60 cells FEBS Letters 365 1995 137
6. Y.X. Zeng W.S. el-Deiry Regulation of p21WAF1/CIP1 expression by p53-independent pathways Oncogene 12 1996 1557
7. W.C. Hooper R.T. Abraham C.L. Ashendel G.E. Woloschak Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cells Biochemica et Biophysica Acta 1013 1989 47
8. Y. Homma M.A. Gemmell E. Huberman Protein kinase C activates with different characteristics, including substrate specificity from two human HL-60 leukemia cell variants Cancer Research 48 1988 2744
9. J. de Vente S. Kiley T. Garris W. Bryant J. Hooker K. Posekany P. Parker P. Cook D. Fletcher D.K. Ways Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation Cell Growth and Differentiation 6 1995 371
10. W.H. Zhu T.T. Loh Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells Biochemistry and Pharmacology 51 1996 1229
11. S. Grant A.J. Turner T.M. Bartimole P.A. Nelms V.C. Joe W.D. Jarvis Modulation of 1-[beta- d -arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C Oncology Research 6 1994 87
12. M.S. Rinaudo K. Su L.A. Falk S. Halder R.A. Mufson Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells Blood 86 1995 80
13. D.A. Tonetti C. Henning-Chub D.T. Yamanishi E. Huberman Protein kinase C-β is required for macrophage differentiation of human HL-60 leukemia cells Journal of Biological Chemistry 269 1994 23230
14. D.A. Tonetti M. Horio F.R. Collart E. Huberman Protein kinase C β gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation Cell Growth and Differentiation 3 1992 739
15. F. Rossi M. McNagny G. Smith J. Frampton T. Graf Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity EMBO Journal 15 1996 1894
16. M.W. Wooten M.L. Seibenhener Y. Soh Expression of protein kinase C isoforms in HL60 and phorbol ester resistant HL525 cells Cytobios 76 1993 19
17. I.B. Weinstein C.M. Borner R.S. Krauss K. O'Driscoll P.M. Choi M. Moritomi S. Hoshina L.-L. Hsieh K.-M. Tchou-Wong S.N. Guadagno M. Ueffing J. Guillem Pleiotropic effects of protein kinase C and the concept of carcinogenesis as a progressive disorder in signal transduction J. Bruge T. Curran E. Harlow F. McCormick Origins of Human Cancer: A Comprehensive Review 1991 Cold Spring Harbor Laboratory Press New York 113
18. D.K. Ways K. Posekany J. deVente T. Garris J. Chen J. Hooker W. Qin P. Cook D. Fletcher P. Parker Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation Cell Growth and Differentiation 5 1994 1195
19. Y. Emoto H. Kisaki Y. Manome S. Kharbanda D. Kufe Activation of protein kinase C delta in human myeloid leukemic cells treated with 1-beta- d -arabinofuranosylcytosine Blood 87 1996 1990
20. M. Yoshida W. Feng N. Saijo T. Ikekawa Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. International Journal of Cancer 66 1996 268
21. D. Leszczynski K. Leszczynski K. Servomaa Long wave ultraviolet radiation causes increase of membrane-bound fraction of protein kinase C in rat myeloid leukemia cells Photodermatology, Photoimmunology and Photomedicine 11 1995 124
22. R.H. Weiss A.P. Yabes R. Sinaee TGF-beta and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways Department of Internal Medicine, Northern California System of Clinics, U.S.A. 48 1995 738
23. C. Lafon P. Mazars M. Guerrin N. Barboule J.Y. Charcosset A. Valette Early gene responses associated with transforming growth factor-beta 1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells Biochimica et Biophysica Acta 1266 1995 288
24. J.A. Elias T. Zheng N.L. Whiting A. Marcovici T.K. Trow Cytokine-cytokine synergy and protein kinase C in the regulation of lung fibroblast leukemia inhibitory factor American Journal of Physiology 266 1994 L426
25. 3 Journal of Leukocyte Biology 59 1996 555
26. J. Savickiene A. Gineitis V.P. Shanbhag T. Stigbrand Protein kinase inhibitors exert stage specific and inducer dependent effects on HL-60 cell differentiation Anticancer Research 15 1995 687
27. K.D. Yang T. Mizobuchi S.M. Kharbanda R. Datta E. Huberman D.W. Kufe R.M. Stone All- trans -retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line Blood 83 1994 490
28. M.F. Denning A.A. Dlugosz D.W. Threadgill T. Magnuson S.H. Yuspa Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta Journal of Biological Chemistry 271 1996 5325
29. D. Geiges F. Marks M. Gschwendt Loss of protein kinase C delta from human HaCaT keratinocytes upon ras transfection is mediated by TGF alpha Experimental Cell Research 219 1995 299
30. K. Nishikawa S. Yamamoto H. Nagumo C. Otsuka R. Kato Suppressive effect of transforming growth factor-beta on the phosphorylation of endogenous substrates by conventional and novel protein kinase C in primary cultured mouse epidermal cells Biochemistry and Bio-physics Research ommunications 193 1993 384
31. A.J. Cowin E.L. Heaton S.H. Cheshire U.K. Bidey The proliferative responses of porcine thyroid follicular cells to epidermal growth factor and thyrotrophin reflect the autocrine production of transforming growth factor-beta 1 Journal of Endocrinology 148 1996 87
32. R.K. Studer P.A. Craven F.R. DeRubertis Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor-beta Journal of Laboratory and Clinical Medicine 125 1995 86
33. S.J. Sheu T. Sakamoto R. Osusky H.M. Wang T.E. Ogden S.J. Ryan D.R. Hinton R. Gopalakrishna Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway Graefes Archives of Clinical and Experimental Oththalmology 232 1994 695
34. M.P. Bos J.M. van der Meer M.P. Herrmann-Erlee Regulation of protein kinase C activity by phorbol ester, thrombin, parathyroid hormone and transforming growth factor-beta 2 in different types of osteoblastic cells Bone Mineralogy 26 1994 141
35. R.M. Niles Use of vitamins A and D in chemoprevention and therapy of cancer: control of nuclear receptor expression and function. Vitamins, cancer and receptors Advances in Experimental Medicine and Biology 375 1995 1
36. L. Hunakova J. Sedlak M. Klobusicka M. Sulikova B. Chorvath Phorbol ester (TPA)-induced differential modulation of cell surface antigens in human pluripotential leukemia (K-562) cell line: effects of protein kinase inhibitors with broad- and PKC selective inhibitory activity Neoplasma 42 1995 249
37. R.A. Baumgartner K. Ozawa J.R. Cunha-Melo K. Yamada F. Gusovsky M.A. Beaven Studies with transfected and permeabilized RBL-2H3 cells reveal unique inhibitory properties of protein kinase C gamma Molecular Biology of the Cell 5 1994 475
38. S.C. Kiley P.J. Parker Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation Journal of Cell Science 108 1995 1003
39. B. Zheng T.C. Chambers R.L. Raynor P.N. Markham H.M. Gebel W.R. Vogler J.F. Kuo Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphates inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein Journal of Biological Chemistry 269 1994 12332
40. W.J. Ryves S. Dimitrijevic P.C. Gordge F.J. Evans HL-60 cell differentiation induced by phorbol- and 12-deoxyphorbol esters Carcinogenesis 15 1994 2501
41. N.R. Murray D.J. Burns A.P. Fields Presence of a beta II protein kinase C-selective nuclear membrane activation factor in human leukemia cells Journal of Biological Chemistry 269 1994 21385
42. D.E. Macfarlane L. Manzel Activation of beta-isozyme of protein kinase C (PKC beta) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PKC beta-defective PET mutant Journal of Biological Chemistry 269 1994 4327